Share this page on LinkedIn
Share This Page on Google+
Share This Page on Twitter
tell someone about this page print this page
You are here: Contents > 2012 > Volume 21 Number 3 May 2012 > AORTIC VALVE DISEASE > Risk of Aortic Valve Replacement in Patients with Aortic Stenosis and Chronic Obstructive Pulmonary Disease

Risk of Aortic Valve Replacement in Patients with Aortic Stenosis and Chronic Obstructive Pulmonary Disease

Daniel B. Spoon, Thomas A. Orszulak, Eric S. Edell, Zhuo Li, Rick A. Nishimura

Divisions of Cardiovascular Disease and Department of Internal Medicine, Cardiovascular Surgery, Pulmonary and Critical Care Medicine, Biostatistics, Mayo Clinic, Rochester, Minnesota, USA

Background and aim of the study: Patients with aortic stenosis (AS) and chronic obstructive pulmonary
disease (COPD) have been considered at high risk for aortic valve replacement (AVR), which results in some patients being denied this life-saving
operation. Hence, the study aim was to assess the operative, 30-day, and long-term mortality in
individuals with COPD undergoing AVR for AS in the modern surgical era.
Methods: This retrospective cohort of patients had documented COPD (FEV1/FVC <70%), and underwent isolated AVR for severe AS between 1993 and 2007 at the Mayo Clinic in Rochester, MN.
Results: Of the 68 patients who met the study criteria, 27 had mild/moderate COPD (FEV1 >50%), 35 had severe COPD (FEV1 30-50%), and six had very severe COPD (FEV1 <30%). The overall operative and 30-day mortality was 4.8%. More severe COPD was associated with a longer stay in the intensive care unit

(42 h for mild/moderate versus 115 h for severe/very severe: p = 0.02), but did not influence the operative or 30-day mortalities. Female gender was associated with an increased length of hospital stay. Long-term mortality was significantly higher in patients with a history of cerebrovascular disease (HR 4.3, p <0.001), NYHA class III or IV heart failure (class III HR 2.79, p = 0.05; class IV HR 3.97, p = 0.03), and increased age (HR 1.06, p = 0.003). The severity of COPD was an independent risk factor for long-term mortality.
Conclusion: Patients with severe AS and COPD are at an acceptable risk for AVR (30-day mortality <5%). The severity of COPD is not associated with an increased in-hospital or 30-day mortality, but does influence long-term mortality.



The Journal of Heart Valve Disease 2012;21:314-319

Risk of Aortic Valve Replacement in Patients with Aortic Stenosis and Chronic Obstructive Pulmonary Disease

Click the above hyperlink to view the article, right click (Ctrl click on a Mac) to open in a new browser window or tab.

Purchase this Article

Please click the button below to purchase this article. Single article purchases are provided at $50.00 per article. Upon clicking the button below, single article user account subscription details are requested and, upon successful payment, a single article user account is created. Single articles are availble in your account for seven days after purchase.